サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1634163

眼科用縫合糸の世界市場 - 2025～2033年

Global Ophthalmic Sutures Market - 2025 - 2033

出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
眼科用縫合糸の世界市場 - 2025～2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

眼科用縫合糸の世界市場は、2024年に4億6,370万米ドルに達し、2033年には8億7,150万米ドルに達すると予測され、予測期間2025年のCAGRは7.3%で成長します。

眼科用縫合糸は、眼球または眼球周辺組織の外科的切開や創傷を閉鎖するために使用される特殊な医療用糸またはストランドです。これらの縫合糸は、正確な組織近似を提供し、治癒をサポートし、デリケートな眼球構造への外傷を最小限に抑えるように設計されています。角膜、強膜、虹彩、眼瞼、眼窩組織などの眼科手術において非常に重要です。眼科用縫合糸は、眼組織の繊細で複雑な性質に合わせて、非常に薄く繊細に作られています。

眼科用縫合糸市場は、眼疾患の有病率の増加や手術技術の進歩などの要因によって、一貫した成長を遂げています。例えば、2024年10月、顕著なサービス、信頼される性能、卓越した価値にコミットする世界の医療技術大手企業であるCorza Medical社は、シカゴで開催された米国眼科学会（AAO）で発表された革新的な眼科マイクロ手術用縫合糸の新ライン「Onatec」を発売しました。

市場力学：

促進要因と阻害要因

眼疾患の有病率の上昇

眼疾患の有病率の上昇が眼科用縫合糸市場の成長を大きく牽引しており、予測期間中も市場を牽引していくとみられます。白内障は、世界中で最も一般的な眼疾患の1つであり、特に高齢化が進んでいます。加齢に伴い、白内障を発症する可能性は高くなります。白内障手術は、世界中で最も一般的に行われている手術のひとつです。

例えば、WK Eye Instituteによると、世界中で毎年およそ2,800万件の白内障手術が行われており、そのうち15％近くが米国で行われています。白内障手術の件数はさらに増加すると予測されており、その結果、眼科用縫合糸の需要が増加します。

糖尿病網膜症は、網膜に影響を及ぼす糖尿病の合併症であり、懸念が高まっています。国際糖尿病連合（IDF）の報告によると、世界には約4億6,300万人の糖尿病患者がおり、そのうち最大28％に糖尿病網膜症のリスクがあるといいます。進行した糖尿病網膜症の治療には、多くの場合、硝子体手術（眼球から硝子体ゲルを取り除く）が行われ、手術中にできた切開創を修復して閉じるための特殊な縫合糸が必要となります。

加齢黄斑変性症（AMD）も、加齢とともに一般的になりつつある眼の疾患です。米国眼科学会によると、2040年までに2億8,800万人がAMDに罹患すると予想されています。AMDは通常、注射のような内科的治療を必要とするが、進行した症例では網膜手術のような外科的介入を必要とする場合があり、眼科用縫合糸は組織の修復と閉鎖に不可欠です。

無縫合手術への移行

無縫合手術技術へのシフトは、眼科用縫合糸市場の成長を妨げると予想されます。眼科用縫合糸は多くの眼科手術に不可欠ですが、無縫合技術の開発と採用により、様々な外科手術における従来の縫合糸への依存度が低下しています。例えば白内障手術では、フェムトセカンド・レーザー技術の採用により縫合糸の必要性が減少しています。この技術により、外科医は正確な角膜切開を行うことができ、多くの場合、閉鎖に縫合糸を必要としません。

外科医は、白内障手術や屈折矯正手術において、自己密封式の角膜切開をますます利用するようになっています。これらの切開は縫合を必要とせずに自然に閉じるため、全体的に縫合の必要性が減少します。この動向は特に屈折矯正手術（レーシック、PRKなど）において顕著であり、小さく正確な切開が行われ、多くの場合縫合糸を使用しないため、回復が早く、傷跡も最小限に抑えられます。

組織接着剤やシアノアクリレート系接着剤は、多くの眼科手術、特に角膜創傷修復や網膜手術などの処置において、縫合糸に代わるものとして人気を集めています。これらの接着剤は、ある種の眼科手術において、より迅速で効率的な閉鎖を提供し、従来の縫合糸と比較して、適用が容易、手術時間の短縮、合併症の減少など、いくつかの利点を提供します。例えば、網膜剥離の手術では、シアノアクリレート系組織接着剤が網膜裂孔の封鎖に使用されることがあり、縫合糸が不要になります。

このレポートの詳細 - サンプル請求

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • タイプ別の抜粋
  • 吸収能力別の抜粋
  • 用途別の抜粋
  • エンドユーザー別の抜粋
  • 地域別の抜粋

第3章 市場力学

  • 影響要因
    • 促進要因
      • 眼疾患の有病率の上昇
    • 抑制要因
      • 無縫合手術への移行
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 眼科用縫合糸市場、タイプ別

  • 天然縫合糸
  • 合成縫合糸

第6章 眼科用縫合糸市場、吸収力別

  • 吸収性縫合糸
  • 非吸収性縫合糸

第7章 眼科用縫合糸市場、用途別

  • 白内障手術
  • 角膜移植手術
  • 硝子体切除手術
  • 虹彩切除手術
  • 眼形成外科
  • その他

第8章 眼科用縫合糸市場、エンドユーザー別

  • 病院
  • 眼科クリニック
  • 外来手術センター
  • その他

第9章 眼科用縫合糸市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • B. Braun SE
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Johnson & Johnson Medical NV.
  • Medtronic plc
  • DemeTECH Corporation
  • Corza Medical
  • KATSAN Katgut Industry and Trade Inc.
  • Golnit
  • Accutome Inc.
  • Aurolab
  • Dolphin Sutures

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD8962

The global ophthalmic sutures market reached US$ 463.7 million in 2024 and is expected to reach US$ 871.5 million by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033.

Ophthalmic sutures are specialized medical threads or strands used to close surgical incisions or wounds in the eye or surrounding ocular tissues. These sutures are designed to provide precise tissue approximation, support healing, and minimize trauma to delicate ocular structures. They are crucial in ophthalmic surgeries, including procedures on the cornea, sclera, iris, eyelids, and orbital tissues. Ophthalmic sutures are extremely thin and delicate to match the sensitive and intricate nature of eye tissues.

The ophthalmic sutures market experiencing consistent growth, driven by factors such as the increasing prevalence of eye disorders and advancements in surgical techniques. For instance, in October 2024, Corza Medical, a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, launched its innovative new line of Onatec ophthalmic microsurgical sutures, unveiled at the American Academy of Ophthalmology (AAO) conference in Chicago.

Market Dynamics: Drivers & Restraints

Rising prevalence of eye disorders

The rising prevalence of eye disorders is significantly driving the growth of the ophthalmic sutures market and is expected to drive the market over the forecast period. Cataracts are one of the most common eye conditions worldwide, particularly in the aging population. As people age, the likelihood of developing cataracts increases. Cataract surgery is one of the most common procedures performed worldwide.

For instance, according to the WK Eye Institute, there are roughly 28 million cataract surgeries performed worldwide each year, with nearly 15 percent occurring in the United States. The number of cataract surgeries is projected to rise further, consequently increasing the demand for ophthalmic sutures.

Diabetic retinopathy, a complication of diabetes that affects the retina, is a growing concern. The International Diabetes Federation (IDF) reports that there are approximately 463 million people with diabetes worldwide, and up to 28% of them are at risk for diabetic retinopathy. Treatment for advanced stages of diabetic retinopathy often involves vitrectomy (removal of the vitreous gel from the eye), which requires specialized sutures to repair and close incisions made during surgery.

Age-related macular degeneration (AMD) is another eye disorder that is becoming more common with aging. By 2040, 288 million people are expected to suffer from AMD, according to the American Academy of Ophthalmology. While AMD typically requires medical treatments like injections, advanced cases may need surgical interventions, such as retinal surgeries, where ophthalmic sutures are essential for tissue repair and closure.

Shift towards sutureless surgical techniques

Shift towards sutureless surgical techniques is expected to hamper the growth of the ophthalmic sutures market. While ophthalmic sutures are essential for many eye surgeries, the development and adoption of sutureless techniques are reducing the dependency on traditional sutures in various surgical procedures. For instance, in cataract surgeries, adopting femtosecond laser technology has reduced the need for sutures. This technology enables surgeons to perform precise corneal incisions that often do not require sutures for closure.

Surgeons are increasingly utilizing self-sealing corneal incisions in cataract and refractive surgeries. These incisions naturally close without requiring sutures, reducing the need for suturing altogether. This trend is particularly evident in refractive surgeries (e.g., LASIK, PRK) where small, precise incisions are made, often without sutures, leading to faster recovery times and minimal scarring.

Tissue adhesives or cyanoacrylate-based glues are gaining popularity as alternatives to sutures in many ophthalmic surgeries, especially for procedures like corneal wound repair and retinal surgeries. These adhesives provide a quicker and more efficient closure for certain types of eye surgeries, offering several advantages over traditional sutures, such as ease of application, reduced surgical time, and fewer complications. For instance, in retinal detachment surgeries, cyanoacrylate tissue adhesives are sometimes used to seal retinal tears, eliminating the need for sutures.

For more details on this report - Request for Sample

Segment Analysis

The global ophthalmic sutures market is segmented based on type, absorption capacity, application, end-user and region.

Absorption Capacity:

The non-absorbable sutures segment is expected to dominate the ophthalmic sutures market share

Non-absorbable sutures are preferred in surgeries where long-term tissue support is crucial, such as scleral or corneal repairs, retinal surgeries, and glaucoma surgeries. These surgeries often involve tissues that take a longer time to heal or need sustained support. For instance, in glaucoma surgeries like trabeculectomy, non-absorbable sutures are used to ensure that the incision remains closed until the wound fully heals. Their ability to provide durable support is essential for reducing the risk of postoperative complications like wound dehiscence (wound opening).

Nylon and polypropylene, the two most common materials used for non-absorbable sutures, offer superior tensile strength and durability compared to absorbable sutures. This makes them ideal for use in areas that experience high mechanical stress or require precise closure. For instance, in corneal surgeries, such as penetrating keratoplasty (corneal transplants), where precise wound closure is critical to prevent infection and ensure proper healing, non-absorbable sutures ensure that the incision site is securely closed for a prolonged period.

Non-absorbable sutures do not dissolve over time, which makes them suitable for applications where the removal of sutures is not necessary. For instance, in cataract surgeries, retinal procedures, or glaucoma surgeries, non-absorbable sutures can remain in place indefinitely without causing issues, reducing the need for follow-up procedures. In cases like eyelid surgeries, the sutures may remain permanently in place, providing lasting structural support to the eyelids.

Geographical Analysis

North America is expected to hold a significant position in the ophthalmic sutures market share

Ophthalmic diseases such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and other vision-related disorders are more prevalent in North America especially in the United States and Canada, particularly due to an aging population and increasing lifestyle-related factors like diabetes. For instance, according to the American Academy of Ophthalmology (AAO), by 2050, the number of people in the U.S. with diabetic retinopathy is expected to rise to 14.6 million, driving an increased need for surgeries that require ophthalmic sutures.

The ophthalmic sutures market in North America benefits from a well-established healthcare market, with high adoption rates of ophthalmic procedures. In particular, cataract surgeries in the U.S. are expected to increase due to the country's aging population and advancements in surgical techniques.

For instance, the National Eye Institute (NEI) projects that cataract surgery in the U.S. alone will rise sharply in the coming decades, from approximately 3.6 million in 2020 to 5.7 million by 2050. Cataract surgeries often require sutures to close the incision, and as the number of surgeries increases, so does the demand for ophthalmic sutures.

Asia-Pacific is growing at the fastest pace in the ophthalmic sutures market

The Asia-Pacific region has a large and growing population that is increasingly affected by a range of eye disorders. Conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and corneal diseases are becoming more prevalent due to an aging population, lifestyle changes, and rising diabetes rates. For instance, Cataracts are a major concern in Asia. The World Health Organization (WHO) estimates that by 2030, over 50 million people in the region will be living with cataracts, and it remains the leading cause of blindness.

In countries like India, China, and Japan, where the aging population is rapidly increasing, the demand for cataract surgeries and related ophthalmic treatments is soaring. Cataract surgery often involves the use of ophthalmic sutures for wound closure, driving the demand for sutures.

For instance, the World Bank's Implementation Completion Report provides information on the major achievements of the Cataract Blindness project in India. Based on an estimated 3.5 million cataract surgeries each year, about 320,000 people are saved from blindness annually. Overall population prevalence of cataract blindness declined by 26 percent, from 1.5 percent at baseline to 1.1 percent, during the program period. These rising cataract surgeries boost the demand for ophthalmic sutures in the region.

Competitive Landscape

The major global players in the ophthalmic sutures market include B. Braun SE, Johnson & Johnson Medical NV., Medtronic plc, DemeTECH Corporation, Corza Medical, KATSAN Katgut Industry and Trade Inc., Golnit, Accutome Inc. Aurolab, Dolphin Sutures and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Ophthalmic Sutures market report delivers a detailed analysis with 70 key tables, more than 64 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Absorption Capacity
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Eye Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. Shift Towards Sutureless Surgical Techniques
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics

5. Ophthalmic Sutures Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Natural Sutures*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Synthetic Sutures

6. Ophthalmic Sutures Market, By Absorption Capacity

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 6.1.2. Market Attractiveness Index, By Absorption Capacity
  • 6.2. Absorbable Sutures*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Absorbable Sutures

7. Ophthalmic Sutures Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cataract Surgery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Corneal Transplantation Surgery
  • 7.4. Vitrectomy Surgery
  • 7.5. Iridectomy Surgery
  • 7.6. Oculoplastic Surgery
  • 7.7. Others

8. Ophthalmic Sutures Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ophthalmic Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. Ophthalmic Sutures Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. B. Braun SE*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Johnson & Johnson Medical NV.
  • 11.3. Medtronic plc
  • 11.4. DemeTECH Corporation
  • 11.5. Corza Medical
  • 11.6. KATSAN Katgut Industry and Trade Inc.
  • 11.7. Golnit
  • 11.8. Accutome Inc.
  • 11.9. Aurolab
  • 11.10. Dolphin Sutures

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us